cGxP.wire https://validator.w3.org/feed/docs/rss2.html Lilac Biosciences Appoints Adriana Coll De Peña as CEO AusperBio Reports 15-Month Hepatitis B Cure With AHB-137 Brii Bio Reports Phase 2 Progress in Hepatitis B Cure ImmunoGenesis Highlights IMGS-203 in Two Cancer Studies Skyhawk Doses First U.S. Patients in Huntington’s Trial Elysium Expands Peptide Access and Launches Research Programs Servier Expands Glioma Portfolio With New Cancer Data Bausch Health’s Salix Highlights Severe Alcohol-Associated Hepatitis Burden Antengene Unveils AnTenGager-D2 Preclinical Cancer Data Innovent Reports Phase 3 Tafolecimab Success in Lipids Novo Reports Wegovy Liver Marker Gains in Adults With MASH Allergan Reports Facial Satisfaction Gains Among GLP-1 Users J&J Reports 73% PSA Response in Advanced Prostate Cancer NYU Langone: Heart Procedures Show No Long-Term Survival Benefit Inimmune Reports Phase 1 INI-4001 Results for Solid Tumors Thermo Fisher Launches AmpSure Universal qPCR Master Mixes Biohaven Advances Pivotal Phase 3 Trial for Graves’ Disease Nuvo REACTIVE Trial Shows Gains in At-Home Fetal Monitoring Amgen Reports 20% Lower Heart Attack Risk With Repatha Zydus Reports Positive Phase 2b Saroglitazar MASH Data Novo Nordisk Reports Real-World Wegovy Benefits in MASH Onkos Wins FDA Clearance to Expand NanoCept Coating Theraclion Wins FDA Authorization for SONOVEIN HIFU Alfasigma Wins EU Approval for Filgotinib in axSpA HUTCHMED Wins FDA Orphan Status for Sovleplenib Acepodia Advances ACE723 Into Phase 1 Trial for Liver Cancer PulseAI Wins FDA Clearance for AI Wearable ECG Analysis MetaVia Reports 68% Liver Fat Reduction With DA-1726 Halozyme’s ENHANZE Powers FDA-Approved Cancer Therapy Johnson & Johnson Wins FDA Nod for RYBREVANT FASPRO ANI Pharmaceuticals’ $560M Offer for Egetis Therapeutics Bid Fairview Selects Layer Health for AI Clinical Registry Automation Rigel to Present Phase 1b R289 Data at ASH 2026 Telix Joins Thera4Care to Advance FAP-Targeted Cancer Therapy Citius Reports LYMPHIR Quality-of-Life Benefits in CTCL Menarini and Ryvu Report First Dapolsertib Phase II Data Bayer Wins China Approval for Sevabertinib in Lung Cancer ImmunityBio Begins European ANKTIVA Treatment Rollout SK Biopharmaceuticals Seeks FDA Expansion for Cenobamate Evident Vascular Wins FDA Clearance for AI IVUS System GE HealthCare Adds AI Features to Vscan Air Ultrasound Verismo Reports Promising SynKIR-310 CAR-T Phase 1 Data Gan & Lee Reports Positive Bofanglutide Phase IIIb Data UCB and Cradle Expand AI-Powered Antibody Discovery Newleos Wins $15.5M NIDA Grant and FDA Fast Track Nxera and AbbVie Sign $1.47B IBD Drug Licensing Deal NOVOS Reports STAMINA Trial Results on Heart Health Pentixapharm Advances Phase 3 PANDA Radiopharmaceutical Study IASO Bio Launches FUCASO CAR-T Therapy in Singapore Concept Medical Reports Three-Year SIRONA Trial Results